Metabolic reprogramming tailors T cell immunity in sepsis

Area of Science:

• Immunology
• Metabolism
• Infectious Diseases

Background:

• Sepsis is a critical condition with high mortality, often complicated by persistent immunosuppression.
• Existing sepsis treatments are limited, especially in restoring immune function.
• Emerging research highlights metabolic reprogramming in T cells during sepsis.

Purpose of the Study:

• To systematically review T-cell metabolic reprogramming mechanisms in sepsis.
• To analyze the impact of these metabolic alterations on T-cell exhaustion and immunosuppression.
• To summarize potential metabolic pathway-targeted therapies for sepsis immunotherapy.

Main Methods:

• Literature review of studies on T-cell metabolism in sepsis.
• Analysis of signaling pathways (HIF-1α, mTOR, AMPK) and metabolic enzymes.
• Examination of T-cell dysfunction, immunosuppression, and secondary infections in sepsis models.
• Summary of therapeutic strategies targeting metabolic pathways.

Main Results:

• Sepsis induces enhanced glycolysis, mitochondrial dysfunction, and altered amino acid metabolism in T cells.
• Signaling pathways and metabolic enzymes mediate these changes, leading to T-cell exhaustion.
• Metabolic reprogramming contributes to immune suppression and susceptibility to secondary infections.
• Therapeutic interventions like IL-7 therapy and IDO1 inhibitors show promise.

Conclusions:

• T-cell metabolic reprogramming is a key mechanism in sepsis-induced immune dysfunction.
• Targeting metabolic pathways presents a promising avenue for novel sepsis immunotherapies.
• Restoring T-cell metabolic function could improve outcomes and reduce mortality in sepsis patients.